Li-Fraumeni Syndrome Association Canada

10/13/2026

We're proud to see OHCRN represented at REACH26, the Li-Fraumeni Syndrome (LFS) Symposium!
Thank you to Chiquita Hessels for including OHCRN on her poster about LFSA Canada's important work.
Chiquita and Bailey Gallinger (also pictured) have been longtime collaborators and supporters of OHCRN. We appreciate their ongoing partnership and commitment to advancing hereditary cancer research and clinical care for those with LFS.
We value our two-way collaboration with Li-Fraumeni Syndrome Association Canada and look forward to continuing to learn from and work alongside the LFS community.
Way to go!

09/23/2026

09/18/2026

https://pcpcrc.ca/studies/improving-advance-care-planning-for-adolescents-and-young-adults-diagnosed-with-cancer-pan-canadian-development-of-voicing-my-choices-canada/

In Canada, over 9,000 adolescents and young adults (AYAs; ages 15-39 years) are diagnosed with cancer each year. For young people with advanced cancer, talking about their end-of-life (EoL) preferences is important, but many don’t get the opportunity to share their wishes. Improving EoL for AYAs i...

09/08/2026

08/28/2026

One more week! Reserve your hotel by September 2 for discounted rates during the 8th International LFS Association Symposium, October 2-5, 2026, at UT MD Anderson Cancer Center in Houston, TX.

The LFSA room block is at the beautiful Blossom Hotel Houston, located in walking distance to Symposium events. https://bit.ly/REACH26hotel

Registration is open for Symposium at https://bit.ly/4vL6sNd (provided complimentary for LFS families). Connect with experts, gain valuable insights, and be part of the collaboration shaping the future of LFS care and research!

08/09/2026

Now accepting abstracts for poster sessions at REACH26, the 8th International LFSA Symposium, taking place Oct. 2-5 in Houston, hosted by UT MD Anderson Cancer Center in partnership with the LiFE Consortium

Researchers, clinicians and advocates are invited to submit an abstract to share your related work and insights to drive progress around Li-Fraumeni syndrome.

Deadline is September 7, submit your abstract at https://bit.ly/4gjac40

06/23/2026

The world lost another incredible person today. Thank you Dr Fraumeni for all you’ve given to the world and the LFS community. As a patient to have met 1/2 of the namesake of this condition I am grateful. With love from my family to yours. Chiquita

The LFSA mourns the loss of Dr. Joseph F. Fraumeni, Jr. (1933 - 2026), one of the world’s premier cancer epidemiologists. His remarkable and vast contributions have forever shaped cancer research worldwide and his role in founding LFSA was pivotal for advocacy and patient support.